Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196905 Synthetic compounds and methods to decrease nicotine self-administration
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196900 Pyridine non-classical cannabinoid compounds and related methods of use
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196886 Combination
08/02/2012US20120196885 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196879 Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors
08/02/2012US20120196876 (9e)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
08/02/2012US20120196874 Stilbene analogs and methods of treating cancer
08/02/2012US20120196871 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
08/02/2012US20120196870 Combination therapy and cancer
08/02/2012US20120196865 Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
08/02/2012US20120196864 Prophylactic or therapeutic agent for cancer
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196859 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
08/02/2012US20120196858 Method of promoting apoptosis and inhibiting metastasis
08/02/2012US20120196855 Oxygen linked pyrimidine derivatives
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196852 Inhibitors of methionine aminopeptidases and methods of treating disorders
08/02/2012US20120196851 Wnt pathway antagonists
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196847 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
08/02/2012US20120196842 Certain chemical entities, compositions, and methods
08/02/2012US20120196839 Compounds as lysophosphatidic acid receptor antagonists
08/02/2012US20120196834 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
08/02/2012US20120196833 Phosphorus containing quinazoline compounds and methods of use
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196828 Sensitization of cancer cells to treatment
08/02/2012US20120196827 Methylation markers for early detection and prognosis of colon cancers
08/02/2012US20120196823 Pharmaceutical compositions of cytidine analogs and methods of use thereof
08/02/2012US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
08/02/2012US20120196814 (R)-1-(4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY)PROPAN-2-OL METABOLITES
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120196805 Compositions and methods to control angiogenesis with cupredoxins
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120196793 Biomarkers for iap inhibitor compounds
08/02/2012US20120196790 Cyclic depsipeptides
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196301 Use of binding partners for 5-ht5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
08/02/2012US20120195988 Therapeutic Uses for Plants of the Capsicum Genus
08/02/2012US20120195978 Capcna peptide therapeutics for cancer
08/02/2012US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers
08/02/2012US20120195961 Use of Spinosyns and Spinosyn Compositions Against Disease Caused By Protozoans, Viral Infections and Cancer
08/02/2012US20120195957 Novel nanoparticle formulations for skin delivery
08/02/2012US20120195953 Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
08/02/2012US20120195935 Microbubble assisted viral delivery
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195918 Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/02/2012US20120195916 Method of treating cancer by inhibiting trim59 expression or activity
08/02/2012US20120195915 IAP BIR domain binding compounds
08/02/2012US20120195912 Cripto Blocking Antibodies and Uses Thereof
08/02/2012US20120195911 Method of treatment of cancer patients
08/02/2012US20120195909 Antibodies against a proliferating inducing ligand (april)
08/02/2012US20120195905 Targeted binding agents directed to dll4 and uses thereof 524
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/02/2012US20120195895 Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof
08/02/2012US20120195892 Immunoglobulin molecules with improved characteristics
08/02/2012US20120195890 Oligonucleotides inhibiting cellular migration
08/02/2012US20120195889 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
08/02/2012US20120195887 Inhibitor Compounds and Cancer Treatment Methods
08/02/2012US20120195876 Novel role of alpha-galactosidase activity as a biomarker in kidney disease
08/02/2012US20120195869 Sickled Erythrocytes with Anti-tumor Agents Induce Tumor Vaso-occlusion and Tumoricidal Effects
08/02/2012US20120195858 Responsiveness to angiogenesis inhibitors
08/02/2012US20120195855 Methods for up-regulating antigen expression in tumors
08/02/2012US20120195854 Granulysin in immunotherapy
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195851 Modified soluble fgf receptor fc fusions with improved biological activity
08/02/2012US20120195850 Use of polymer d-lactic acid (pdla) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers
08/02/2012US20120195834 Method of testing a drug for anti-cancer activity
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012US20120195831 Generation, characterization and uses thereof of anti-her3 antibodies
08/02/2012US20120195830 Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012US20120195826 Injectable biomaterial
08/02/2012DE102011009961A1 7-Azaindolderivate 7-azaindole derivatives
08/02/2012CA2826034A1 Stilbene analogs and methods of treating cancer
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/02/2012CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012CA2825306A1 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
08/02/2012CA2825255A1 Antibodies selective for cells presenting egfr at high density
08/02/2012CA2823824A1 Derivatives of azaindazole or diazaindazole type as medicament
08/02/2012CA2823774A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
08/01/2012EP2481802A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
08/01/2012EP2481801A1 Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of neoplasia
08/01/2012EP2481800A2 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof
08/01/2012EP2481755A1 Antibody capable of recognizing hla class i
08/01/2012EP2481754A1 Specific binding proteins and uses thereof
08/01/2012EP2481748A2 Foxp3 peptide vaccine
08/01/2012EP2481739A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
08/01/2012EP2481736A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/01/2012EP2481725A1 Substituted amide compound
08/01/2012EP2481429A2 MMP Activated Vascular Disrupting Agents
08/01/2012EP2481428A2 MMP activated vascular disrupting agents
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 2211